netFormulary
 Report : A-Z HCD items in Formulary 11/07/2020 16:13:58
[Back]
 
Section Status BlueTeq Name
10.01.03 Restricted Use BlueTeq Adalimumab Rheumatology
11.04.02 Restricted Use BlueTeq Adalimumab Opthalmology
13.05.03 Restricted Use BlueTeq Adalimumab Dermatology
08.02.04 Restricted Use BlueTeq Alemtuzumab 
10.02 Restricted Use BlueTeq Ataluren Translarna
10.01.03 Restricted Use BlueTeq Belimumab 
03.04.02 Restricted Use BlueTeq Benralizumab Fasenra®
08.02.04 Restricted Use BlueTeq Beta-interferon-1a Avonex®
08.02.04 Restricted Use BlueTeq Beta-interferon-1b Extavia®
08.02.04 Restricted Use BlueTeq Beta-interferon-1b Betaferon®
05.03.03 Restricted Use BlueTeq Boceprevir 
20 Restricted Use BlueTeq Bosentan (Rheumatology) 
03.04.03 Restricted Use BlueTeq C1-Esterase Inhibitor  Berinert®
08.02.04 Restricted Use BlueTeq Canakinumab Ilaris®
08.02.04 Restricted Use BlueTeq Cladribine Mavenclad®
05.03.03 Restricted Use BlueTeq Daclatasvir  
05.03.03 Restricted Use BlueTeq Dasabuvir  
08.02.04 Restricted Use BlueTeq Dimethyl Fumarate  
05.03.03 Restricted Use BlueTeq Elbasvir and grazoprevir Zepatier®
04.08.01 Formulary BlueTeq Everolimus Votubia
08.02.04 Restricted Use BlueTeq Fingolimod Gilyena®
08.02.04 Restricted Use BlueTeq Glatiramer Acetate 
08.02.04 Restricted Use BlueTeq Glatiramer Acetate 
05.03.03 Restricted Use BlueTeq Glecaprevir and pibrentasvir Maviret®
01.05 Restricted Use BlueTeq Infliximab (Inflectra®) Gastroenterology
08.02.04 Restricted Use BlueTeq Interferon beta 
08.02.04 Formulary BlueTeq Interferon beta-1a Rebif®
05.03.03 Restricted Use BlueTeq Ledipasvir and sofosbuvir  Harvoni®
03.04.02 Restricted Use BlueTeq Mepolizumab Nucala®
08.02.04 Restricted Use BlueTeq Natalizumab  Tysabri®
03.11 Restricted Use BlueTeq Nintedanib 
01.09.01 Restricted Use BlueTeq Obeticholic acid 
08.02.04 Restricted Use BlueTeq Ocrelizumab Ocrevus®
03.04.02 Restricted Use BlueTeq Omalizumab Xolair®
05.03.03 Restricted Use BlueTeq Ombitasvir, paritaprevir, and ritonavir  Viekirax®
05.03.05 Restricted Use BlueTeq Palivizumab Synagis®
03.11 Restricted Use BlueTeq Pirfenidone  
09.01.07 Restricted Use BlueTeq Plerixafor  
05.03.03 Restricted Use BlueTeq Sofosbuvir 
05.03.03 Restricted Use BlueTeq Sofosbuvir, velpatasvir, voxilaprevir Vosevi®
05.03.03 Restricted Use BlueTeq Sofosbuvir/valpatasvir Epclusa®
05.03.03 Restricted Use BlueTeq Telaprevir 
08.02.04 Restricted Use BlueTeq Teriflunomide  Aubagio®
01.05 Restricted Use BlueTeq Ustekinumab Gastroenterology
01.05 Restricted Use BlueTeq Vedolizumab  
Leicestershire Health Community